Market Segmentation Drug Type Insights (Revenue, USD BN, 2021 - 2033) Exenatide Liraglutide Sitagliptin Saxagliptin Alogliptin Others Disease Indication Insights (Revenue, USD BN, 2021 - 2033) Type 2 Diabetes Mellitus (T2DM) Weight Management Others Distribution Channel Insights (Revenue, USD BN, 2021 - 2033) Online Pharmacies Retail Pharmacies Hospital Pharmacies Regional Insights (Revenue, USD BN, 2021 - 2033) North America U.S
Return to moderate exercise typically possible
Brcic, L., Seiwerth, S., Vuletic, L
126 Administration of CoQ10 in doses ranging from 60mg500 mg/day significantly decreased production of inflammatory markers
Initial investigations may include complete blood count, metabolic panel, thyroid function tests, hemoglobin A1c, ESR/CRP, HIV testing, and urinalysis when clinically indicated